Presentation New Randomized Trial Data (2-Year Outcomes): EVERBIO II Presenter: Serban Puricel October 14, 2015 REGISTER for free or LOG IN to view this content Presentation TCT 2015 Up Next Presentation The FDA-Mandated Postapproval Study of the Amplazter ASO Device Presenter: Zahid Amin October 14, 2015 More slides + Presentation Early Stage New TAVR Systems: Trinity Valve Technology Review and Clinical Update Presenter: Christian Hengstenberg October 14, 2015 Presentation Nordic IV Study: One vs 2 Stents Presenter: Jens Flensted Lassen October 14, 2015 We Recommend
Presentation The FDA-Mandated Postapproval Study of the Amplazter ASO Device Presenter: Zahid Amin October 14, 2015
Presentation Early Stage New TAVR Systems: Trinity Valve Technology Review and Clinical Update Presenter: Christian Hengstenberg October 14, 2015